Updates & Highlights
TradingKey · about 1 month ago
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
Seeking Alpha · about 1 month ago
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT)
TradingView · about 1 month ago
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Nautilus Biotechnology?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentNautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
TradingKey · about 1 month ago
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT)
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT)
Seeking Alpha · about 1 month ago
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT
TradingView · about 1 month ago
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates
Kalkine · about 1 month ago
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary
TradingView · about 1 month ago
Nautilus Biotechnology (NASDAQ: NAUT) posts $29.2M loss but holds $129.2M in cash and investments
Nautilus Biotechnology (NASDAQ: NAUT) posts $29.2M loss but holds $129.2M in cash and investments
Stock Titan · about 1 month ago
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology Q2 Earnings Call Highlights
Yahoo Finance · about 1 month ago
Earnings call transcript: Nautilus Biotechnology beats Q2 2026 EPS forecast
Earnings call transcript: Nautilus Biotechnology beats Q2 2026 EPS forecast
Investing.com · about 1 month ago
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
TradingView · about 1 month ago
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Investing News Network · about 1 month ago
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
TradingView · about 1 month ago
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
GlobeNewswire · about 1 month ago
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Yahoo Finance · about 1 month ago
NAUT|Nautilus Biotechnology Inc|Price:1.035|Chg%:-0.165
NAUT|Nautilus Biotechnology Inc|Price:1.035|Chg%:-0.165
TradingKey · about 1 month ago
Nautilus Biotechnology reports Q2 2026: $0.2M revenue, $14.5M net loss, $129.2M cash
Nautilus Biotechnology reports Q2 2026: $0.2M revenue, $14.5M net loss, $129.2M cash
TradingView · about 1 month ago
BRIEF-Nautilus Biotechnology Q2 EPS USD -0.11
BRIEF-Nautilus Biotechnology Q2 EPS USD -0.11
TradingView · about 1 month ago
Nautilus Biotechnology Reports $190,000 Revenue in Second Quarter 2026
Nautilus Biotechnology Reports $190,000 Revenue in Second Quarter 2026
Quiver Quantitative · about 1 month ago
Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...
Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...
Yahoo Finance · about 1 month ago
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology Q2 Earnings Call Highlights
MarketBeat · about 1 month ago
Nautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results
Nautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results
Stock Titan · about 1 month ago